Cargando…
Post-capillary venules are the key locus for transcytosis-mediated brain delivery of therapeutic nanoparticles
Effective treatments of neurodegenerative diseases require drugs to be actively transported across the blood-brain barrier (BBB). However, nanoparticle drug carriers explored for this purpose show negligible brain uptake, and the lack of basic understanding of nanoparticle-BBB interactions underlies...
Autores principales: | Kucharz, Krzysztof, Kristensen, Kasper, Johnsen, Kasper Bendix, Lund, Mette Aagaard, Lønstrup, Micael, Moos, Torben, Andresen, Thomas Lars, Lauritzen, Martin Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257611/ https://www.ncbi.nlm.nih.gov/pubmed/34226541 http://dx.doi.org/10.1038/s41467-021-24323-1 |
Ejemplares similares
-
Blood–Brain Barrier Transport of Transferrin Receptor-Targeted Nanoparticles
por: Thomsen, Maj Schneider, et al.
Publicado: (2022) -
Apolipoprotein M-bound sphingosine-1-phosphate regulates blood–brain barrier paracellular permeability and transcytosis
por: Mathiesen Janiurek, Mette, et al.
Publicado: (2019) -
Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration
por: Andersen, Hjalte Holm, et al.
Publicado: (2013) -
Divalent metal transporter 1 (DMT1) in the brain: implications for a role in iron transport at the blood-brain barrier, and neuronal and glial pathology
por: Skjørringe, Tina, et al.
Publicado: (2015) -
Transcytosis of albumin in capillary endothelium
Publicado: (1987)